Search results
neffy 2 mg is a nasal spray used to treat life-threatening, allergic emergencies including anaphylaxis, in adults and children who weigh 66 lbs or more (30 kg or more), who are at risk for or have a history of serious allergic emergencies.
Aug 12, 2024 · Neffy is a nasal spray containing epinephrine that may be used for the emergency treatment of life-threatening, allergic reactions including anaphylaxis in adults and children weighing 66 pounds or more (30 kilograms or more) with a history of, or risk factors for, serious allergic reactions.
Aug 9, 2024 · CNN — The US Food and Drug Administration approved the first nasal spray epinephrine drug for severe allergic reactions known as anaphylaxis, providing a needle-free alternative to EpiPens and...
2 days ago · Today, the U.S. Food and Drug Administration approved neffy (epinephrine nasal spray) for the emergency treatment of allergic reactions (Type I), including those that are life-threatening ...
The new nasal spray is a needle-free alternative to the auto-injector devices. It is a 2 mg spray approved for adult and pediatric patients weighing at least 66 pounds. A neffy prescription consists of two single-dose nasal spray devices. Each device is a single dose administered into one nostril.
Aug 15, 2024 · Neffy (epinephrine nasal) is used for the treatment of serious allergic reactions, including anaphylaxis. Neffy is used only during emergencies. Anyone using Neffy should seek medical care...
Side Effects. Nasal discomfort, runny nose, sneezing, irritation of the throat, headache, shaking, nervousness, numbness, tiredness, dizziness, nausea, or vomiting may occur. If any of these ...
Oct 21, 2022 · The company is developing neffy® (previously referred to as ARS-1), an intranasal epinephrine product in clinical development for patients and their caregivers with Type I allergic reactions including food, medications and insect bites that could lead to life-threatening anaphylaxis.
May 11, 2023 · neffy PK data bracketed between approved epinephrine products – neffy shows greater PD response vs IM injection • neffy comparable to IM for patients under nasal challenge
Neffy, a single-dose nasal spray administered into one nostril, was approved for use in adult and pediatric patients who weigh at least 66 pounds.
